Alan S Perelson

John McHutchison, Ruy M Ribeiro, Alan S Perelson, 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Modeling HIV persistence, the latent reservoir, and viral blips.

Libin Rong, Alan S Perelson, A. Perelson, 2009, Journal of theoretical biology.

Towards multiscale modeling of influenza infection.

Michael S Murillo, Alan S Perelson, A. Perelson, 2013, Journal of theoretical biology.

Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy.

Harel Dahari, Ruy M Ribeiro, Alan S Perelson, 2007, Journal of theoretical biology.

Estimates of Intracellular Delay and Average Drug Efficacy from Viral Load Data of HIV-Infected Individuals under Antiretroviral Therapy

Alan S Perelson, A. Perelson, D. Ho, 2004, Antiviral therapy.

Mathematical analysis of delay differential equation models of HIV-1 infection.

Patrick W Nelson, Alan S Perelson, A. Perelson, 2002, Mathematical biosciences.

Modeling the mechanisms of acute hepatitis B virus infection.

Stanca M. Ciupe, Patrick W Nelson, Ruy M Ribeiro, 2007, Journal of theoretical biology.

Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?

Fabien Zoulim, Alan S Perelson, A. Perelson, 2008, The Journal of antimicrobial chemotherapy.

Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility.

Libin Rong, Zhilan Feng, Alan S Perelson, 2007, Journal of theoretical biology.

Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration

Daniel R Kuritzkes, Ruy M Ribeiro, Alan S Perelson, 2017, PLoS pathogens.

Modeling amantadine treatment of influenza A virus in vitro.

Ruy M Ribeiro, Alan S Perelson, A. Perelson, 2008, Journal of theoretical biology.

Modeling the Effects of Vaccination on Chronically Infected HIV‐Positive Patients

Alan S Perelson, A. Perelson, L. E. Jones, 2002, Journal of acquired immune deficiency syndromes.

Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus

Ruy M Ribeiro, Alan S Perelson, James Blanchard, 2005, European journal of immunology.

Modelling deuterium labelling of lymphocytes with temporal and/or kinetic heterogeneity

Ruy M Ribeiro, Alan S Perelson, A. Perelson, 2012, Journal of The Royal Society Interface.

Dynamic Antibody Specificities and Virion Concentrations in Circulating Immune Complexes in Acute to Chronic HIV-1 Infection

Feng Gao, David C Montefiori, Frederik Graw, 2011, Journal of Virology.

Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents.

Libin Rong, Alan S Perelson, A. Perelson, 2013, Mathematical biosciences.

Post-treatment control of HIV infection

Jessica M Conway, Alan S Perelson, A. Perelson, 2015, Proceedings of the National Academy of Sciences.

The role of cells refractory to productive infection in acute hepatitis B viral dynamics

Geoffrey Dusheiko, Stanca M. Ciupe, Patrick W Nelson, 2007, Proceedings of the National Academy of Sciences.

Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues

Alan S Perelson, Stephen W Wietgrefe, Ann Thorkelson, 2014, Proceedings of the National Academy of Sciences.

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Hui Li, Tanmoy Bhattacharya, Xiping Wei, 2008, Proceedings of the National Academy of Sciences.

Modeling sequence evolution in acute HIV-1 infection.

Tanmoy Bhattacharya, Michael S Saag, Brian Gaschen, 2009, Journal of theoretical biology.

Dynamic characteristics of HIV-1 reservoirs

Alan S Perelson, A. Perelson, Hwijin Kim, 2006, Current opinion in HIV and AIDS.

HIV dynamics with multiple infections of target cells.

Alan S Perelson, A. Perelson, N. Dixit, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Treatment of Hepatitis C with An Interferon-Based Lead-In Phase: A Perspective from Mathematical Modelling

Libin Rong, Harel Dahari, Jeremie Guedj, 2014, Antiviral therapy.

Backward bifurcations and multiple equilibria in epidemic models with structured immunity.

Jan Medlock, Timothy C. Reluga, Alan S Perelson, 2008, Journal of theoretical biology.

Nonlatching positive feedback enables robust bimodality by decoupling expression noise from the mean

Youfang Cao, Leor S Weinberger, Michael L Simpson, 2017, bioRxiv.

Effect of target cell availability on HIV-1 production in vitro

Jay Rappaport, Alan S Perelson, A. Perelson, 2002, AIDS.

Modeling Long-Term HIV Dynamics and Antiretroviral Response: Effects of Drug Potency, Pharmacokinetics, Adherence, and Drug Resistance

Hulin Wu, Edward P Acosta, Daniel R Kuritzkes, 2005, Journal of acquired immune deficiency syndromes.

An age-structured model of hiv infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells.

Daniel Coombs, Patrick W Nelson, Alan S Perelson, 2004, Mathematical biosciences and engineering : MBE.

Modeling HCV kinetics under therapy using PK and PD information.

Ruy M Ribeiro, Alan S Perelson, A. Perelson, 2009, Expert opinion on drug metabolism & toxicology.

Transient Viremia, Plasma Viral Load, and Reservoir Replenishment in HIV-Infected Patients on Antiretroviral Therapy

Alan S Perelson, A. Perelson, L. E. Jones, 2007, Journal of acquired immune deficiency syndromes.

The complexity of complexes in signal transduction

James R Faeder, Byron Goldstein, Michael L Blinov, 2003, Biotechnology and bioengineering.

Hepatitis C viral kinetics: the past, present, and future.

Anushree Chatterjee, Alan S Perelson, A. Perelson, 2013, Clinics in liver disease.

A stochastic model of cytotoxic T cell responses.

Stephanie Forrest, Alan S Perelson, S. Forrest, 2004, Journal of theoretical biology.

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life

Libin Rong, Harel Dahari, Jeremie Guedj, 2013, Proceedings of the National Academy of Sciences.

HIV-1 infection and low steady state viral loads

Alan S Perelson, A. Perelson, D. Callaway, 2002, Bulletin of mathematical biology.

Stochastic model of an influenza epidemic with drug resistance.

Alan S Perelson, A. Perelson, L. Allen, 2007, Journal of theoretical biology.

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production.

Harel Dahari, Alan S Perelson, Marian Major, 2005, Gastroenterology.

Evaluation of Multitype Mathematical Models for CFSE-Labeling Experiment Data

Hulin Wu, Hongyu Miao, Alan S Perelson, 2012, Bulletin of mathematical biology.

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Feng Gao, Hui Li, Guido Ferrari, 2012, The Journal of clinical investigation.

Modeling Viral Spread.

Frederik Graw, Alan S Perelson, A. Perelson, 2016, Annual review of virology.

Modeling Quasispecies and Drug Resistance in Hepatitis C Patients Treated with a Protease Inhibitor

Libin Rong, Ruy M Ribeiro, Alan S Perelson, 2012, Bulletin of mathematical biology.

Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis

Sebastian Bonhoeffer, Alan S Perelson, John E Mittler, 1999, The Lancet.

Modelling Hepatitis C virus Kinetics: The Relationship between the Infected Cell Loss rate and the Final Slope of Viral Decay

Harel Dahari, Alan S Perelson, A. Perelson, 2008, Antiviral therapy.

Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses

Richard A Neher, Alan S Perelson, A. Perelson, 2012, Journal of statistical mechanics.

Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.

Harel Dahari, Jeremie Guedj, Alan S Perelson, 2011, Current hepatitis reports.

Modeling of Influenza-Specific CD8+ T Cells during the Primary Response Indicates that the Spleen Is a Major Source of Effectors

Hulin Wu, Hongyu Miao, Gabrielle T Belz, 2011, The Journal of Immunology.

Dynamics of hepatitis B virus infection.

Ruy M Ribeiro, Alan S Perelson, A. Perelson, 2002, Microbes and infection.

Triphasic decline of hepatitis C virus RNA during antiviral therapy

Harel Dahari, Ruy M Ribeiro, Alan S Perelson, 2007, Hepatology.

Mathematical modeling of within‐host Zika virus dynamics

Katharine Best, Alan S Perelson, A. Perelson, 2018, Immunological reviews.

Understanding silibinin's modes of action against HCV using viral kinetic modeling.

Harel Dahari, Jeremie Guedj, Alan S Perelson, 2012, Journal of hepatology.

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

Bing Li, Fan Li, Jing Chen, 2016, The lancet. Gastroenterology & hepatology.

Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments

Shingo Iwami, Yoshiki Koizumi, Alan S Perelson, 2017, Proceedings of the National Academy of Sciences.

Modeling T Cell Proliferation and Death in Vitro Based on Labeling Data: Generalizations of the Smith–Martin Cell Cycle Model

Alan S Perelson, A. Perelson, H. Y. Lee, 2008, Bulletin of mathematical biology.